Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.35 |
| ▸ | P2RY10 | O00398 | 2/20 | 0.31 |
| ▸ | GPR174 | Q9BXC1 | 2/20 | 0.31 |
| ▸ | NMT2 | O60551 | 1/20 | 0.31 |
| ▸ | NMT1 | P30419 | 1/20 | 0.31 |
| ▸ | PLA2G4A | P47712 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6372215 | 0.88 | PLA2G2C (0.46) | PLA2G2CP2RY10GPR174 | |
| SCHEMBL15022342 | 0.88 | PLA2G2C (0.46) | PLA2G2CP2RY10GPR174 | |
| SCHEMBL8504216 | 0.82 | P2RY10 (0.45) | P2RY10GPR174 | |
| SCHEMBL1864332 | 0.77 | P2RY10 (0.42) | P2RY10GPR174 | |
| SCHEMBL2329616 | 0.77 | P2RY10 (0.42) | P2RY10GPR174 | |
| SCHEMBL1867684 | 0.77 | P2RY10 (0.42) | P2RY10GPR174 | |
| SCHEMBL14777667 | 0.75 | SMN1; SMN2 (0.46) | — | |
| SCHEMBL4737508 | 0.74 | PLA2G2C (0.45) | PLA2G2CP2RY10GPR174 | |
| SCHEMBL9951880 | 0.74 | PLA2G2C (0.45) | PLA2G2CP2RY10GPR174 | |
| SCHEMBL9951445 | 0.74 | PLA2G2C (0.45) | PLA2G2CP2RY10GPR174 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050186230-A1 | Elemene compositions containing liquid oil | SD PHARMACEUTICALS, INC. (US) | 2005-08-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050186230-A1 | Elemene compositions containing liquid oil | ELOVL5, LIPA, AQP1 | PLA2G2C 481/4885P2RY10 4501/4885GPR174 3069/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.